) and CFTR Cl-
channel blocker. Inhibits Kir
6 currents in the pancreas, causing an increase in intracellular Ca2+
and insulin secretion. Inhibits recombinant CFTR Cl- channels with an IC50
of 20 μ
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Glibenclamide: a review.
Brogden et al.
Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride channels.
Sheppard and Welsh
Potassium channel modulators: scientific applications and therapeutic promise.
Robertson et al.
The citations listed below are publications that use Tocris products. Selected citations for Glibenclamide include:
Showing Results 1 - 10 of 11